Skip to main content
Premium Trial:

Request an Annual Quote

Smiths Detection Wins NIH Grant for Flu Dx

NEW YORK (GenomeWeb News)— Smiths Detection has received a $2.2 million grant from the National Institutes of Health to develop a PCR-based test for multiple influenza types in humans, the London-based company said.

The two-year grant from the National Institute of Allergy and Infectious Diseases will support development of a test that will use LATE PCR technology on the company’s Bio-Seeq instrument and may be administered at the point of care or in a conventional lab.

Smiths Detection licensed the LATE PCR nucleic acid amplification technology from Brandeis University.

The firm also is developing a similar test for diagnosing influenza infections in animals that will use desktop and portable versions of the Bio-Seeq system.

"The pandemic influenza application makes excellent use of the full range of our diagnostic technologies, combining the need for a sophisticated highly multiplexed test with the need for rapid results at the point of care," Bill Mawer, who heads Smith Detections diagnostics business, said in a statement.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.